CD8A and type 1 diabetes mellitus: In order to validate the YES-RIP-hB7.1 mice as a model to study T cells in T1D, we characterized CD8+ T-cell responses in 12- to 20-week-old diabetic mice and control mice that remained diabetes-free up to 30 weeks of age as previously reported (11).